NSC |
Compound |
Enrichment |
Correlation |
NSC 107043 |
Null |
0.0219024304994663 |
0.048035754 |
NSC 120925 |
Null |
0.0219024304994663 |
0.57525411 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0219024304994663 |
0.11584046 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0219024304994663 |
0.10309689 |
NSC 149765 |
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) |
0.0219024304994663 |
-0.071489357 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.0219024304994663 |
0.27795174 |
NSC 208885 |
Null |
0.0219024304994663 |
0.39859118 |
NSC 287069 |
Epicorazine A |
0.0219024304994664 |
0.052471342 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.0219024304994664 |
0.47222511 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.0219024304994664 |
0.31798638 |